sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard's Disclosure on Spire Healthcare Stake
On February 6, 2026, The Vanguard Group, Inc. disclosed its investment position in Spire Healthcare Group plc. This announcement follows the requirements outlined in Rule 8.3 of the Takeover Code. The disclosure reveals that Vanguard holds a 3.58% stake in Spire, amounting to 14,431,765 ordinary shares.
The filing indicates that as of February 5, 2026, Vanguard had no cash-settled or stock-settled derivative positions. Additionally, no new securities' subscription rights were declared in the current disclosure. Vanguard's recent activity included purchasing 2,502 ordinary shares at a price of 2.02 GBP each.
No indemnity or other dealing arrangements were reported, nor were there any agreements or understandings related to options or derivatives. The form does not include any Supplemental Form 8, suggesting no open positions. The disclosure was finalized by Shawn Acker, emphasizing transparency in Vanguard's dealings.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.